Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care

April 30, 2018 updated by: Margaret Campbell, Wayne State University
This study is a pilot test of an intervention to train family caregivers of home hospice patients about recognizing and treating shortness of breath.

Study Overview

Status

Completed

Conditions

Detailed Description

Shortness of breath is a prevalent symptom causing distress among patients at the end of life. In home hospice care family caregivers are expected to assist their family member with symptom management. This is often accomplished with little or no training.

The investigators have developed a bundle of training materials targeted for family caregivers of home hospice patients at risk for shortness of breath. The investigators will pilot test the intervention in this clinical trial. A future randomized clinical trial is planned and the evidence from this pilot will enhance the planning of that future trial.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Livonia, Michigan, United States
        • Angela Hospice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient in home hospice care with an estimated survival of 3-4 weeks, at risk for dyspnea secondary to lung cancer, COPD, or heart failure.
  • Family caregiver in patient's home must speak and read English.

Exclusion Criteria:

  • Patients with bulbar ALS or quadriplegia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
all participants will receive the training
Hospice registered nurses will train family caregivers about how to recognize patient shortness of breath. This training will employ a guided learning tool the Respiratory Distress Observation Scale-Family. Training will be done with a DVD and return demonstration of the skills using the patient. In addition, the family will be taught the bundle of evidence-based interventions to treat shortness of breath.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in patient respiratory comfort
Time Frame: Baseline and up to four weeks until patient death
The Respiratory Distress Observation Scale will be used to measure patient respiratory comfort at enrollment (baseline), twice each week during the study until patient death.
Baseline and up to four weeks until patient death

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family caregiver burden index
Time Frame: Baseline and participants will be followed for an average of 4 weeks until date of death
The Modified Caregiver Strain Index
Baseline and participants will be followed for an average of 4 weeks until date of death

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family caregiver stress as measured by Salivary cortisol
Time Frame: Baseline and participants will be followed for an average of four weeks to end at time of death.
Salivary cortisol
Baseline and participants will be followed for an average of four weeks to end at time of death.
Family anxiety questionnaire
Time Frame: Baseline and participants will be followed for an average of four weeks to end at time of death
Promis anxiety Short form
Baseline and participants will be followed for an average of four weeks to end at time of death
Family depression questionnaire
Time Frame: Baseline and participants will be followed for an average of four weeks to end at time of death
Baseline and participants will be followed for an average of four weeks to end at time of death

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Margaret L. Campbell, PhD, Wayne State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2015

Primary Completion (Actual)

April 30, 2018

Study Completion (Actual)

April 30, 2018

Study Registration Dates

First Submitted

April 30, 2015

First Submitted That Met QC Criteria

May 7, 2015

First Posted (Estimate)

May 12, 2015

Study Record Updates

Last Update Posted (Actual)

May 3, 2018

Last Update Submitted That Met QC Criteria

April 30, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • RDOS-Family

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyspnea

Clinical Trials on Shortness of breath recognition and treatment

Subscribe